SCR-LIP-000275 · Claim · machine-readable JSON →
Using a previously validated online screening questionnaire (cutoff ≥12 points, AUC 0.8615, specificity 0.88, sensitivity 0.46, PPV 0.767), a population-representative study estimated lipedema prevalence at 12.3% among Brazilian women aged 18-69, corresponding to roughly 8.8 million women with suggestive symptoms.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Prevalência e fatores de risco para lipedema no Brasil — Amato et al. (2022) ✓ verified — consistent · cross sectional · 2022 · reading confidence: high
The article applies a validated screening tool to estimate high lipedema prevalence in a large population, directly demonstrating that screening instruments can identify suspected lipedema cases and supporting the notion of substantial undi
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? consistent
- Can screening tools or questionnaires help identify lipedema cases? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000004